USA - NASDAQ:INVA - US45781M1018 - Common Stock
ChartMill assigns a Buy % Consensus number of 80% to INVA. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-09-30 | Goldman Sachs | Initiate | Sell |
| 2025-08-11 | Oppenheimer | Initiate | Outperform |
| 2025-08-11 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-07-14 | HC Wainwright & Co. | Initiate | Buy |
| 2025-07-11 | Cantor Fitzgerald | Initiate | Overweight |
| 2025-03-07 | ScotiaBank | Initiate | Sector Outperform |
| 2024-08-01 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-07-30 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-06-20 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-06-18 | Cantor Fitzgerald | Initiate | Overweight |
| 2023-05-10 | EF Hutton | Reiterate | Buy |
| 2023-04-20 | EF Hutton | Reiterate | Buy |
| 2023-03-03 | EF Hutton | Reiterate | Buy |
| 2023-03-03 | Goldman Sachs | Maintains | Neutral |
| 2023-03-03 | Morgan Stanley | Maintains | Underweight |
| 2023-01-24 | Morgan Stanley | Maintains | Underweight |
| 2022-10-13 | Morgan Stanley | Maintains | Underweight |
| 2022-08-08 | Morgan Stanley | Maintains | Underweight |
| 2022-07-20 | Goldman Sachs | Initiate | Neutral |
| 2022-07-15 | Morgan Stanley | Maintains | Underweight |
| 2022-04-12 | Morgan Stanley | Maintains | Underweight |
| 2022-02-23 | Morgan Stanley | Maintains | Underweight |
| 2022-02-11 | EF Hutton | Initiate | Buy |
11 analysts have analysed INVA and the average price target is 41.82 USD. This implies a price increase of 138.02% is expected in the next year compared to the current price of 17.57.
The consensus rating for INNOVIVA INC (INVA) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.